VEGF and IL‐1 act inversely as the risk factors in the treatment of thromboangiitis obliterans by revascularization [50], and IL-1 may induce VEGF production in chondrocytes through distinct signaling pathways [51]. The gene discussed is IL1B; the disease is thromboangiitis obliterans.